Doctors call Moderna, Merck's cancer vaccine data a major advancement — even as stocks fall

Beneath the chaos surrounding Moderna and Merck's latest data on their personalized cancer vaccine, oncologists see something else: an important milestone in melanoma treatment. The companies on Thurs...

本文内容来自外部来源，点击「继续访问」将跳转到原始发布站点。